medigraphic.com
SPANISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 4

<< Back Next >>

Ann Hepatol 2008; 7 (4)

Which is the real genotype distribution of hepatitis C virus infection in Mexico?

Idrovo AJ, Fernández JA
Full text How to cite this article

Language: English
References: 11
Page: 390-391
PDF size: 90.39 Kb.


Key words:

No keywords

Text Extraction

Dear editor

Few years ago the distribution of hepatitis C virus (HCV) genotypes in Mexico was unknown. An important exception is the study written by Alvarado-Esquivel et al in 1998. That study reported results of 516 blood donors from 21 states obtained in two referrals blood-banks, and 235 patients with liver disease from the States of Mexico, Jalisco, Michoacan and Oaxaca. In the last year four studies on this topic were published in different journals, even one in Annals of Hepatology. These new studies intended to obtain «national representativeness». The genotypic variability of HCV has implications that included differences in pathogenecity, sensitivity of diagnostic techniques, response to treatment, and vaccine efficacy. For this reason it’s important to review the methodology used in each study, and their findings (consistencies and inconsistencies). Afterwards, it will be possible to define a better picture of the genotype distribution of HCV in Mexico. In this sense, it is important to remember that, in addition to clinical objectives for each infected patient, from a public health perspective the occurrence recognition of a disease is one important step to identify and promote preventive strategies, and define cost-effectiveness treatments. In this letter we want to analyze briefly the methodology used in these papers, and propose a national distribution of HCV genotypes.


REFERENCES

  1. Alvarado-Esquivel C, Wyseur A, Herrera-Ortíz FM, Ruiz-Maya L, Ruiz-Astorga R, Zarate-Aguilar A, et al. Hepatitis B and C virus infections in Mexico: genotypes and geographical distribution in blood donors and patients with liver disease. In: Schinazi RF, Sommadossi JP, Thomas HC (editors). Therapies for viral hepatitis. London: International Medical Press, 1998:35-41.

  2. Sánchez-Ávila JF, González E, Vázquez V, Suárez S, Uribe M. Geographical distribution of HCV genotypes in Mexico. Ann Hepatol 2007; 6: 156-60.

  3. Kato N. Molecular virology of hepatitis C virus. Acta Med Okayama 2001; 55: 133-59.

  4. Lunel F, Stuyverl, Brechot C, Maertens G. Mise au point sur le virus de l’hepatitis C: variabilité et implications. Transfuns Clin Biol 1998; 5: 147-65.

  5. Majid AM, Gretch DR. Current and future hepatitis C virus diagnostic testing: problems and advancements. Microbes Infect 2002; 4: 1227-36.

  6. Zein NN. Clinical significance of hepatitis C genotypes. Clin Microbiol Rev 2000; 13: 223-235.

  7. Chiquete E, Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review. Intervirology 2007; 50: 1-8.

  8. Dehesa-Violante M, Bosques-Padilla F, Kershenobich-Stalnikowitz D. Prevalence of hepatitis C virus genotypes in Mexican patients. Rev Gastroenterol Mex 2007; 72: 344-8.

  9. Dehesa-Violante M, Bosques-Padilla F, Kershenobich-Stalnikowitz D, Bazán-Pérez C, Torres-Ibarra R, Chávez-Oest JA. Prevalencia de genotipos del virus de hepatitis C de pacientes mexicanos (abstract). Rev Gastroenterol Mex 2002; 67: 140A–141A.

  10. Santos-López G, Sosa-Jurado F, Vallejo-Ruiz V, Meléndez-Mena D, Reyes-Leyva J. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infect 2008; 56: 281-90.

  11. Silva LC. La subjetividad se disfraza. En: Cultura estadística e investigación científica en el campo de la salud: una mirada crítica. Madrid: Díaz de Santos; 1997: 263-84.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2008;7